NasdaqCM:IMAC

Stock Analysis Report

Executive Summary

IMAC Holdings, Inc. provides orthopedic therapies through a chain of innovative medical advancements and care regeneration centers in the United States.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • IMAC Holdings has significant price volatility in the past 3 months.
  • IMAC Holdings is not covered by any analysts.

Share Price & News

How has IMAC Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-8.1%

IMAC

0.008%

US Healthcare

-0.2%

US Market


1 Year Return

n/a

IMAC

-9.0%

US Healthcare

1.1%

US Market

No trading data on IMAC.

No trading data on IMAC.


Share holder returns

IMACIndustryMarket
7 Day-8.1%0.008%-0.2%
30 Day-12.3%-0.8%2.5%
90 Day-9.4%-1.5%1.6%
1 Yearn/a-7.6%-9.0%3.4%1.1%
3 Yearn/a29.6%24.4%45.2%35.8%
5 Yearn/a66.2%56.2%62.6%44.8%

Price Volatility Vs. Market

How volatile is IMAC Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is IMAC Holdings undervalued based on future cash flows and its price relative to the stock market?

2.61x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for IMAC Holdings to establish if it is available at moderate discount.

Unable to calculate intrinsic value for IMAC Holdings to establish if it is available at substantial discount.


Price Based on Earnings

IMAC Holdings is loss making, we can't compare its value to the US Healthcare industry average.

IMAC Holdings is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for IMAC Holdings, we can't assess if its growth is good value.


Price Based on Value of Assets

IMAC Holdings is overvalued based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is IMAC Holdings expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as IMAC Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has IMAC Holdings performed over the past 5 years?

-338.1%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

IMAC Holdings does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.

Unable to compare IMAC Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare IMAC Holdings's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if IMAC Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if IMAC Holdings has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if IMAC Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is IMAC Holdings's financial position?


Financial Position Analysis

IMAC Holdings's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

IMAC Holdings's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

IMAC Holdings's level of debt (39.6%) compared to net worth is satisfactory (less than 40%).

Unable to establish if IMAC Holdings's debt level has increased without past 5-year debt data.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 1.1x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

IMAC Holdings has less than a year of cash runway based on current free cash flow.

IMAC Holdings has less than a year of cash runway if free cash flow continues to grow at historical rates of 35.4% each year.


Next Steps

Dividend

What is IMAC Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate IMAC Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate IMAC Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as IMAC Holdings has not reported any payouts.

Unable to verify if IMAC Holdings's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as IMAC Holdings has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of IMAC Holdings's salary, the management and board of directors tenure and is there insider trading?

2.8yrs

Average management tenure


CEO

Jeffrey Ervin (41yo)

4.5yrs

Tenure

US$201,500

Compensation

Mr. Jeffrey S. Ervin is Chairman, Chief Executive Officer & Co-Founder of IMAC Holdings since March 2015. Mr. Ervin earned his M.B.A. from Vanderbilt University and has a history of working within strategi ...


CEO Compensation Analysis

Jeffrey's remuneration is lower than average for companies of similar size in United States of America.

Jeffrey's compensation has increased whilst company is loss making.


Management Age and Tenure

2.8yrs

Average Tenure

44.5yo

Average Age

The tenure for the IMAC Holdings management team is about average.


Board Age and Tenure

0.6yrs

Average Tenure

49yo

Average Age

The average tenure for the IMAC Holdings board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Sheri Gardzina (50yo)

    CFO & Corporate Secretary

    • Tenure: 0.4yrs
  • Jeff Ervin

    Chief Executive Officer

    • Tenure: 0yrs
  • Jeffrey Ervin (41yo)

    Chairman & CEO

    • Tenure: 4.5yrs
    • Compensation: US$201.50k
  • Matthew Wallis (45yo)

    COO & Director

    • Tenure: 4.5yrs
    • Compensation: US$6.00k
  • Ian White (44yo)

    Chief Scientific Officer

    • Tenure: 1.1yrs

Board Members

  • Deke Ellwanger (63yo)

    Director

    • Tenure: 0.6yrs
  • Dean Weiland (63yo)

    Director

    • Tenure: 0.6yrs
  • George Hampton (49yo)

    Director

    • Tenure: 0.6yrs
  • Jeffrey Ervin (41yo)

    Chairman & CEO

    • Tenure: 4.5yrs
    • Compensation: US$201.50k
  • Matthew Wallis (45yo)

    COO & Director

    • Tenure: 4.5yrs
    • Compensation: US$6.00k

Company Information

IMAC Holdings, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: IMAC Holdings, Inc.
  • Ticker: IMAC
  • Exchange: NasdaqCM
  • Founded: 2000
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$30.685m
  • Shares outstanding: 8.41m
  • Website: https://www.imacregeneration.com

Number of Employees


Location

  • IMAC Holdings, Inc.
  • 1605 Westgate Circle
  • Brentwood
  • Tennessee
  • 37027
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IMACNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDFeb 2019
I02DB (Deutsche Boerse AG)YesCommon StockDEEURFeb 2019

Biography

IMAC Holdings, Inc. provides orthopedic therapies through a chain of innovative medical advancements and care regeneration centers in the United States. Its outpatient medical clinics provide regenerative, ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 01:32
End of Day Share Price2019/09/19 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.